Cardlytics (CDLX) Operating Expenses (2017 - 2026)

Cardlytics (CDLX) has reported Operating Expenses for 10 consecutive years, with $42.3 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Operating Expenses fell 37.4% year-over-year to $42.3 million; the trailing twelve-month figure through Jun 2026 stood at $268.0 million (down 38.12% YoY), and the FY2025 full-year result was $335.1 million, down 29.28% from the prior year.
• Operating Expenses eased to $42.3 million in Q2 2026 per CDLX's latest filing, from $42.6 million in the prior quarter.
• Across five years, Operating Expenses topped out at $465.1 million in Q4 2022 and bottomed at $32.3 million in Q1 2022.
• Historically, Operating Expenses has averaged $115.5 million across 5 years, with a median of $83.9 million in 2024.
• The sharpest annual moves came in 2022 and 2023: Operating Expenses surged 336.92% in 2022, then slumped 58.7% in 2023.
• Over 5 years, Operating Expenses stood at $465.1 million in 2022, then plunged by 58.7% to $192.1 million in 2023, then tumbled by 57.15% to $82.3 million in 2024, then retreated by 24.45% to $62.2 million in 2025, then tumbled by 31.95% to $42.3 million in 2026.
• According to Business Quant data, Operating Expenses over the past three periods registered $42.3 million, $42.6 million, and $62.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.